Radiopharm Theranostics Limited
Radiopharm Theranostics Limited (RADX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
radx · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$10.50
+149.4% upside
Low
$6.00
Median: $10.5 · Last Close: $4.21
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$10.50
149.4% upside
High Target
$15
256.3%
Low Target
$6
42.5%
Current Price
$4.21
as of today
Based on analyst price targets, the RADX stock price prediction for the next 12 months ranges from $6 to $15. The consensus RADX price forecast of $10.50 implies 149.4% upside from the current price of $4.21.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.16 | ↓ 1.10% |
1-day model range: $4.14–$4.19. Peak: $4.19 (-1.10%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RADX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-12-16 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-26 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Radiopharm Theranostics Limited (RADX) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover RADX.
Analyst Recommendation Trends
RADX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 90.3% YoY
Revenue Next Year
$3M
↑ 10.1% YoY
EPS This Year
$-4.82
EPS Next Year
$-5.88
↑ 21.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast RADX EPS of $-4.82 for the current fiscal year, based on estimates from 2 analysts. The RADX revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RADX stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RADX price target is $10.50 (+149.4% upside), with an analyst consensus of Buy.
The RADX short-term stock prediction for tomorrow is $4.16 (-1.10%).
Radiopharm Theranostics Limited trades on NASDAQ under the ticker RADX. The RADX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
RADX forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month RADX price target is $10.50, with a high forecast of $15.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +149.4% potential upside from the current price of $4.21.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.